Axia Journal of Hematology and Oncology (AJHO)

Open science is essential to solving the world’s urgent challenges

About

Supporting researchers to open up every output from their research, including publications and preprints, data, code, protocols, methods, and peer review.

By enabling researchers to share their research openly, together we can increase its use and re-use, speed up scientific advances, deliver efficiencies for research, foster collaboration between disciplines, enable easier translation into economic and societal impact, and improve trust in science. That’s why we support open science across all academic disciplines. By enabling open science practices, and collaborating with partners across the scholarly ecosystem, faster and more effective research systems can be created that operate sustainably and at scale and build an equitable research landscape. 

Explore

Aims and Scope – Axia Journal of Hematology and Oncology (AJHO)

The Axia Journal of Hematology and Oncology (AJHO) is a peer-reviewed, open-access journal dedicated to publishing high-quality research, clinical advancements, and innovative treatments in hematology and oncology. Our mission is to provide a platform for hematologists, oncologists, researchers, and healthcare professionals to share groundbreaking discoveries that improve the understanding, diagnosis, and treatment of blood disorders and cancers.

Scope:

  • Hematologic Malignancies – Leukemia, lymphoma, multiple myeloma, and emerging targeted therapies.
  • Solid Tumors – Breast cancer, lung cancer, colorectal cancer, prostate cancer, and rare malignancies.
  • Molecular and Precision Oncology – Genomics, biomarker research, and personalized medicine approaches in cancer treatment.
  • Immuno-Oncology and Cancer Immunotherapy – CAR-T cell therapy, checkpoint inhibitors, and immune response mechanisms.
  • Stem Cell Transplantation and Cellular Therapy – Advances in bone marrow transplantation and stem cell-based therapies.
  • Benign Hematology – Anemia, sickle cell disease, hemophilia, and thrombophilia.
  • Coagulation Disorders and Thrombosis – Hemostasis, anticoagulation therapies, and venous thromboembolism management.
  • Pediatric Hematology and Oncology – Childhood cancers, blood disorders, and pediatric treatment innovations.
  • Hematopoiesis and Bone Marrow Disorders – Myelodysplastic syndromes, aplastic anemia, and bone marrow failure syndromes.
  • Radiation Oncology – Innovations in radiotherapy techniques, proton therapy, and radiation toxicity management.
  • Surgical Oncology – Advances in tumor resection, robotic surgery, and multidisciplinary cancer treatment.
  • Palliative and Supportive Care in Oncology – Pain management, quality of life improvement, and end-of-life care.
  • Oncologic Emergencies – Management of tumor lysis syndrome, spinal cord compression, and febrile neutropenia.
  • Clinical Trials and Drug Development – Novel anti-cancer agents, phase I-III trials, and FDA-approved therapies.
  • Cancer Epidemiology and Prevention – Risk factor identification, screening programs, and lifestyle interventions for cancer prevention.

AJHO serves hematologists, oncologists, radiation oncologists, medical researchers, pathologists, and healthcare professionals dedicated to advancing hematology and oncology research and clinical practice.

The journal follows a rigorous peer-review process, ensures international visibility through indexing in major scientific databases, and promotes rapid publication to disseminate high-impact research in hematology and oncology.

Keywords

Hematology Oncology Leukemia Lymphoma Multiple Myeloma Breast Cancer Lung Cancer Colorectal Cancer Prostate Cancer Molecular Oncology Cancer Biomarkers Cancer Immunotherapy CAR-T Cell Therapy Stem Cell Transplantation Anemia and Blood Disorders Thrombosis and Hemostasis Venous Thromboembolism Pediatric Hematology-Oncology Bone Marrow Disorders Radiation Oncology Surgical Oncology Palliative Oncology Cancer Prevention and Screening Oncologic Emergencies Clinical Trials in Oncology Precision Medicine in Cancer

Peer Review Process

 As an academic publisher, Axia Scientific Publishers ensures that open access makes cutting-edge research widely accessible, enabling it to be read, shared, and built upon. This fosters interdisciplinary knowledge exchange, informs policy-making, and benefits the general public.

Manuscript Submission

Explore how to publish your research article, book, or chapter with Axia Scientific Publishers and make your work widely accessible.

Open access enhances research visibility, increases citations, and promotes trust and reproducibility—benefiting researchers, institutions, and their funders.

Assignment to Reviewers

Our dedicated support team assists authors in identifying potential open access funding sources and provides guidance on the application process.

Peer Review Evaluation

Axia Scientific Publishers supports transformative open access agreements, streamlining funding and workflows to accelerate the transition to open research.